Boston University
room 765 Commonwealth Ave
arrow_back See all Activities

HZI CIR - Small molecule inhibitors of α-hemolysin for the treatment of S. aureus lung infections

IATI Identifier: US-EIN-04-2103547-Helmhltz CIR

Published on IATI
  • date_range Oct 01, 2020 - May 31, 2024
  • autorenew Implementation (Status)

TBD

more_horiz
Sectors:
  • Infectious disease control

Participating Organisations

HZI CIR Academic, Training and Research Implementing

Transaction

Transaction Value Provider
Receiver
Type Date
338,824 USD Provider N/A Receiver N/A Expenditure
date_range Jan 25, 2024
100,000 USD Provider N/A Receiver N/A Expenditure
date_range Aug 31, 2023

Budget

438,824 USD
  • 100,000 USD (Valued at Aug 31, 2023)
    date_range Jul 01, 2022 - Jun 30, 2023
  • 338,824 USD (Valued at Jun 08, 2023)
    date_range Oct 01, 2020 - Oct 31, 2020
access_time Updated on Jan 25, 2024 22:33:25